Jeffrey Biskup

CRB
Executive Chairman of the Board
Jeffrey A. Biskup, PE co-founded Clark, Richardson and Biskup, Consulting Engineers Inc. (CRB) in 1984 and currently serves as the firm’s CEO and Board Chairman. The company has been a part of 18 FOYA winners and been recognized as ISPE Company of the Year three times. Jeff currently plays a key role in CRB’s international growth and overall leadership development. Jeff received his B.S. in Mechanical Engineering from the University of Missouri and has over 25 years of experience in engineering design for pharmaceutical facilities and processes. He is a licensed Professional Engineer in the U.S., Canada and Puerto Rico. Currently, he serves on the Board of Directors for the Missouri Biotechnology Industry Organization. In 1999, he was honored with an FDA Commissioners Citation. Jeff was a key part of the Original ISPE Biopharmaceutical Manufacturing Facilities Baseline® Guide, the Original Baseline Guide for Water and Steam Systems as well as other Baseline® Guides. In addition, he is also a long-standing member of the ISPE Guidance Document Committee (previously known as the Technical Documents Steering Committee). Jeff was elected to the ISPE Board of Directors in 2014 and served through September 2016. More recently Jeff served as the Co-Chair of the ISPE Facilities of the Future Conference in February of 2019 thru 2021. He also was a part of the programming committee for the ISPE Biomanufacturing Conferences in 2016 and 2017.

Related Articles

Board-Chair_Jeffrey_Biskup
Insights
Message from the Chair: Exploring Regulatory Trends and Quality Initiatives with ISPE

ISPE is proud to celebrate its 45th anniversary of working with regulators and professionals from across the industry and around the world to shape the future of pharma. This year also marks the 20th anniversary of the ISPE Facility of the Year Awards (FOYA), which celebrates extraordinary achievements in pharmaceutical manufacturing.

Board-Chair_Jeffrey_Biskup
Insights
Message from the Chair: How ISPE Is Empowering Pharma’s AI Evolution

ISPE is dedicated to advancing AI and digital transformation for the industry. The ISPE International Board of Directors fully supports this initiative. We are making significant strides in supporting the pharmaceutical industry’s pursuit of digital transformation, including the exploration and potential strategic implementation of AI.

Board-Chair_Jeffrey_Biskup
Insights
Message from the Chair: ISPE Guides and Resources on Biopharma, ATMPs, and C&GT

Biopharmaceuticals continue to proliferate in the pharmaceutical industry leading to advancements in advanced therapy medicinal products (ATMPs), cell and gene therapy (C&GT), and other biological products. ISPE supports its membership base of over 22,000 members across more than 120 countries by informing strategies, supporting solutions, and improving processes in this continually...

Board-Chair_Jeffrey_Biskup
Insights
Message from the Chair: ISPE’s Regulatory, Technical, and Quality Leadership

Our March/April issue focuses on the workforce of the future. This is a critical theme for us: ISPE’s vision includes a focus on member and workforce development, as well as technical, regulatory, and quality leadership, as we continue to shape the future of the global pharmaceutical industry. This is particularly important with the industry’s growing skills gap.

Board-Chair_Jeffrey_Biskup
Insights
Message from the Chair: Celebrating 45 Years of Innovation

For nearly half a century, ISPE has served as a resource for the industry. With a global footprint that includes 22,000 members representing 120 countries, we continue to provide guidance to address pressing challenges within the industry.